跳至主要内容
临床试验/NCT04467372
NCT04467372已完成不适用

The Effects Supplementation of Tart Cherry or Placebo on the Gut Microbiome, Inflammation, Oxidative Stress, and Health-related Outcomes.

Ohio University2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
2
主要终点
Changes in glucose regulation assessed via glycated albumin (%).

研究概览

简要总结

There has been a rapid increase in researching the use of tart cherry supplements in the past 5 years, particularly for inflammatory conditions. Many formulations of cherry supplements exist, however there has been no comparison between these different types. This is particularly important in the realm of inflammation research because sugar is known to increase the inflammatory response. The pill form of cherry supplementation has no added sugar and is naturally low in sugar (< 1g) while the juice form is higher from added sugar. Recent work indicates tart cherry consumption can change gut microbiota, which may modify inflammation. The purpose of this study is to look at the effects of taking a cherry supplement, either in capsule or juice form, on the gut microbiome, inflammation, and health-related variables such as blood pressure, glucose regulation and sleep quality.

详细描述

Participants will consume a tart cherry or placebo product for 30 days and attend 5 visits in the Exercise Physiology Lab at Ohio University over the 30 day period. They will self-collect a stool sample at baseline, 14 days and 30 days after supplementation. Blood samples will be taken at baseline, 7 days, 14 days, and 30 days after supplementation. Throughout the study participates will rate symptoms (stomach, head, etc.), pain and sleep quality using an online survey for which the link will be emailed. Participants will maintain normal diet and exercise routine and to track these for the duration of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-55 years old
  • participate in 150 minutes of exercise per week
  • non-smoker
  • have no known allergy to cherries or cherry juice
  • are not taking food supplements (turmeric/curcumin, cherry products, greens, etc.). -You must have access to the internet and be willing to record your food intake, physical activity and sleep quality/duration during the study.

排除标准

  • not 18-55 years old.
  • have quit smoking less than one year ago.
  • have been diagnosed with a metabolic disorder such as diabetes, thyroid disorder, or high cholesterol.
  • are currently being treated for arthritis or an inflammatory condition, such as arthritis, gout, lupus or Sjogren's syndrome.
  • are currently being treated for cardiovascular disease, high blood pressure, fibromyalgia, or irritable bowel syndrome.
  • are pregnant.
  • regularly consume cherries or are allergic to cherries.
  • currently use anti-inflammatory medications.
  • have used corticosteroids in the last two months.
  • are not willing to follow a low polyphenol diet.
  • are not willing to have blood drawn on 4 occasions.
  • are not willing to provide a stool sample on 3 occasions.
  • do not have access to the internet.

结局指标

主要结局

Changes in glucose regulation assessed via glycated albumin (%).

时间窗: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in glucose regulation assessed via insulin (mIU/L)

时间窗: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in inflammation measured via erythrocyte sedimentation rate (mm/hour)

时间窗: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in sleep quantity (hours and minutes) assessed via daily survey.

时间窗: daily for 30 days

Changes in sleep quality measured via 100mm visual analogue scale.

时间窗: daily for 30 days

Changes in gut microbiome bacterial counts

时间窗: baseline, 14 days, and 30 days post supplementation.

Changes in inflammation measured via tumor necrosis factor alpha (pg/mL)

时间窗: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in inflammation measured via c-reactive protein (mg/L) and uric acid (mg/dL).

时间窗: baseline, 7 days, 14 days, and 30 days post supplementation.

Changes in glucose regulation assessed via plasma glucose (mg/dL)

时间窗: baseline, 7 days, 14 days, and 30 days post supplementation.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Angela Hillman

Assistant Professor

Ohio University

研究点 (2)

Loading locations...

相似试验